Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428411 | Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors | Jianming Bao, James P. Roane | 2025-09-30 |
| 12414952 | Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use | Zachary G. Brill, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +10 more | 2025-09-16 |
| 12410159 | Preparation of oxindole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors | Jianming Bao, James P. Roane | 2025-09-09 |
| 11976061 | Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors | Eric R. Ashley, Jianming Bao, Chen Cheng, James P. Roane, Emma Helen Southgate | 2024-05-07 |
| 11787810 | Diacylglyceride O-acyltransferase 2 inhibitors | Cedric Lorenz Hugelshofer, Victor W. Mak, James P. Roane, Jillian R. Sanzone, Samantha E. Shockley +1 more | 2023-10-17 |
| 11498923 | Substituted imidazo[1,2-c]quinazolines as A2A antagonists | Gioconda V. Gallo-Etienne, Joseph M. Kelly, Michael Y. Berlin, Pauline C. Ting, Hongwu Wang | 2022-11-15 |
| 11046714 | 2,2-difluorodioxolo A2A receptor antagonists | Ali Amjad, Gioconda V. Gallo, Timothy J. Henderson, Rongze Kuang, Michael Man-Chu Lo +6 more | 2021-06-29 |
| 10822338 | Substituted aminoquinazoline compounds as A2A antagonist | Amjad Ali, Xianhai Huang, Rongze Kuang, Heping Wu, Rajan Anand +6 more | 2020-11-03 |
| 10472347 | Aminopyrazine compounds with A2A antagonist properties | Rongze Kuang, Pauline C. Ting, Amjad Ali, Heping Wu, Michael Y. Berlin +6 more | 2019-11-12 |
| 10344039 | Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use | Amjad Ali, Jiayi Xu, Wei Zhou | 2019-07-09 |
| 10214512 | Factor XIA inhibitors | Jiayi Xu, Amjad Ali, Wei Zhou, Ying-Duo Gao, Scott D. Edmondson +9 more | 2019-02-26 |
| 10138212 | Aminoquinazoline compounds as A2A antagonist | Amjad Ali, Rongze Kuang, Michael Man-Chu Lo, Pauline C. Ting, Purakkattle Biju +21 more | 2018-11-27 |
| 10093683 | Factor XIa inhibitors | Zhuyan Guo, Amjad Ali, Scott D. Edmondson, Weiguo Liu, Gioconda V. Gallo-Etienne +16 more | 2018-10-09 |
| 10011615 | Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties | Amjad Ali, Michael Man-Chu Lo, Andrew Stamford, Rongze Kuang, Paul Tempest +14 more | 2018-07-03 |
| 9708347 | Heterobicyclo-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties | Amjad Ali, Michael Man-Chu Lo | 2017-07-18 |
| 9676780 | Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties | Amjad Ali, Michael Man-Chu Lo, Andrew Stamford, Rongze Kuang, Paul Tempest +19 more | 2017-06-13 |
| 8524697 | C20-C21 substituted glucocorticoid receptor agonists | John C. Anthes, Kevin D. McCormick, John Hey, Robert G. Aslanian, Purakkattle Biju +5 more | 2013-09-03 |